Literature DB >> 18433337

Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.

Jyh-You Liu1, Hsi-Hsun Lin, Yung-Ching Liu, Susan Shin-Jung Lee, Ya-Lei Chen, Chien-Ching Hung, Wen-Chien Ko, Chun-Kai Huang, Chung-Hsu Lai, Yao-Shen Chen, Yi-Li Shih, Hsing-Chun Chung, Shiou-Haur Liang, Jiun-Nong Lin.   

Abstract

BACKGROUND: An outbreak of human immunodeficiency virus (HIV) type 1 infection among injection drug users (IDUs) occurred in Taiwan, and thereafter, injection drug use became the most frequent risk factor for HIV infection in Taiwan. We sought to study the prevalence of and genotypes causing hepatitis C virus (HCV) infection among HIV-infected IDUs in Taiwan.
METHODS: A multicenter, longitudinal cohort study of 990 HIV-infected IDUs was conducted from 1993 through 2006. Blood samples were collected and analyzed for the presence of antibody to HCV and to determine the genotype of HCV.
RESULTS: The overall prevalence of HCV infection among HIV-infected IDUs was 96.6%. The annual prevalence increased from 65.5% before 2002 to 98.6% in 2006. The main circulating HCV genotypes were 1a (accounting for 29.2% of samples), 6a (23.5%), and 3a (20.2%), whereas 1b, the most predominant genotype circulating in the general population in Taiwan, accounted for only 13.2% of samples. Genotypes 2b (accounting for 6.6% of samples), 6k (2.9%), 2a (1.6%), 6g (1.6%), and 3b (1.2%) were present in only a few IDUs. Multivariate logistic regression analysis revealed that duration of injection drug use and a travel history to China or Southeast Asia were significantly associated with infection due to HCV genotypes 1a, 3, and 6.
CONCLUSIONS: Our study demonstrated a high prevalence of HCV infection among HIV-infected IDUs in Taiwan, with a predominance of infection due to genotypes 1a, 6a, and 3a, as a result of the impact of IDUs' behavior and their drug trafficking route. Our study revealed that HCV infection in IDUs originated from a geographically large transmission network that was mainly distinct from that associated with other HCV-infected individuals; this transmission network has also been documented in association with HIV infection in IDUs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18433337     DOI: 10.1086/587992

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

1.  Molecular epidemiology of hepatitis D virus infection among injecting drug users with and without human immunodeficiency virus infection in Taiwan.

Authors:  Sui-Yuan Chang; Chia-Ling Yang; Wei-Shin Ko; Wen-Chun Liu; Chi-Ying Lin; Cheng-Hsin Wu; Yi-Chin Su; Shu-Fang Chang; Mao-Yuan Chen; Wang-Huei Sheng; Chien-Ching Hung; Shan-Chwen Chang
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

2.  Yeast oropharyngeal colonization in human immunodeficiency virus-infected patients in central taiwan.

Authors:  Mao-Wang Ho; Yun-Liang Yang; Chih-Chao Lin; Chih-Yu Chi; Hui-Ting Chen; Po-Chang Lin; Li-Yun Hsieh; Chia-Hui Chou; Wen-Li Chu; Chiou-Pyng Wu; Tsai-Ling Lauderdale; Hsiu-Jung Lo
Journal:  Mycopathologia       Date:  2014-05-08       Impact factor: 2.574

Review 3.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 4.  Changing patterns of HIV epidemic in 30 years in East Asia.

Authors:  S Pilar Suguimoto; Teeranee Techasrivichien; Patou Masika Musumari; Christina El-saaidi; Bhekumusa Wellington Lukhele; Masako Ono-Kihara; Masahiro Kihara
Journal:  Curr HIV/AIDS Rep       Date:  2014-06       Impact factor: 5.071

5.  Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factors.

Authors:  Hsin-Yun Sun; Sui-Yuan Chang; Zong-Yu Yang; Ching-Lan Lu; Hsiu Wu; Chang-Ching Yeh; Wen-Chun Liu; Chia-Yin Hsieh; Chien-Ching Hung; Shan-Chwen Chang
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

6.  HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China.

Authors:  Chiyu Zhang; Nana Wu; Jun Liu; Qinjuan Ge; Yan Huang; Qian Ren; Qingchuan Feng; Guangli He
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

7.  HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses.

Authors:  Yongshui Fu; Weibing Qin; Hong Cao; Ru Xu; Yi Tan; Teng Lu; Hongren Wang; Wangxia Tong; Xia Rong; Gang Li; Manqiong Yuan; Chunhua Li; Kenji Abe; Ling Lu; Guihua Chen
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

8.  Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts.

Authors:  Victoria L Demetriou; Leondios G Kostrikis
Journal:  BMC Res Notes       Date:  2011-10-31

9.  Human genomics and preparedness for infectious threats.

Authors:  Nicole F Dowling; Marta Gwinn; Alison Mawle
Journal:  Genome Med       Date:  2009-12-29       Impact factor: 11.117

10.  Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection.

Authors:  Meng-Hsuan Hsieh; Jih-Jin Tsai; Ming-Yen Hsieh; Chung-Feng Huang; Ming-Lun Yeh; Jeng-Fu Yang; Ko Chang; Wei-Ru Lin; Chun-Yu Lin; Tun-Chieh Chen; Jee-Fu Huang; Chia-Yen Dai; Ming-Lung Yu; Wan-Long Chuang
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.